Suppression of intestinal crypt cell proliferation and aberrant crypt foci by dietary quercetin in rats

Quercetin inhibits proliferation of human gastric and colonic cancer cells in vitro by suppressing mitosis and increasing apoptosis. Quercetin might therefore act as an anticarcinogen in the alimentary tract, but previous findings have been inconsistent. We fed rats quercetin at dietary concentrations of 1, 5, 20, and 50 g/kg. At less than or equal to20 g/kg, we observed a statistically significant reduction in the frequency of crypt cell mitosis in proximal, mid, and distal small intestine and in distal colon, amounting to similar to40% of control at 1 g/kg. There was no effect on apoptosis. Quercetin metabolites, but not quercetin aglycone, were detected in plasma of rats fed quercetin at 20 and 50 g/kg. In a second experiment, rats were fed quercetin at 1 g/kg after treatment with 1, 2-dimethylhydrazine to induce aberrant crypt foci. In dimethylhydrazine-treated and control rats, crypt cell mitosis was suppressed at 48 h and 42 days after injection, and there was a statistically significant reduction in the number of aberrant crypts and larger aberrant crypt foci (>4 crypts/focus) in the distal colon of treated animals. These findings demonstrate that quercetin can inhibit intestinal crypt cell proliferation in vivo, but the effect diminishes as the level of dietary exposure. increases. At low concentrations, dietary quercetin inhibits induction of aberrant crypts by a mechanism that does not involve increased crypt cell apoptosis.